Featured Research

from universities, journals, and other organizations

Combined aerobic, resistance training, rather than either method alone, is best for controlling blood sugar in people with diabetes

Date:
July 2, 2014
Source:
Diabetologia
Summary:
Combined aerobic and resistance training, rather than either alone, is best for controlling both blood sugar and blood fat profiles among people with type 2 diabetes, a systematic review and meta-analysis of available data suggests. To date, no systematic review has compared the direct and indirect effects of these three different training modalities on the outcomes of blood sugar control and blood fats in patients with type 2 diabetes.

A systematic review and meta-analysis of available data published in Diabetologia (the journal of the European Association for the Study of Diabetes) suggests that combined aerobic and resistance training, rather than either alone, is best for controlling both blood sugar and blood fat profiles among people with type 2 diabetes. However the authors stress that the strength of the results is weakened when studies with high risk of bias are removed, and thus more high quality trials are needed to make more definitive conclusions. The study is by Lukas Schwingshackl, University of Vienna, Austria, and colleagues.

To date, no systematic review has compared the direct and indirect effects of these three different training modalities on the outcomes of blood sugar control and blood fats in patients with type 2 diabetes. The aim of the present study was to assess the efficacy of aerobic exercise training (AET), resistance training (RT) and combined training (CT) on blood sugar control, blood pressure and blood fats in patients with type 2 diabetes in a systematic review and meta-analysis.

A total of 14 trials enrolling 915 participants were included. The results showed that, in patients with established diabetes, AET might be more effective in reducing HbA1c (a measure of blood sugar control) and fasting glucose when compared with RT. CT was more powerful in reducing HbA1c compared with AET, and more effective in reducing HbA1c, fasting blood glucose and blood fats when compared with RT. However, these results could not be confirmed when only low risk of bias studies were included. Pooling both direct and indirect evidence on AET, RT and CT via meta-analysis demonstrated that CT was the most efficacious exercise intervention regarding its impact on HbA1c, fasting glucose, good cholesterol, blood fats, diastolic blood pressure and bodyweight.

The authors note that only studies where the training was supervised (and thus objectively validated) were included in the analysis. There is evidence that supervised exercise is more effective than unsupervised training, but in practice it seems unlikely that most patients would have access to supervised exercise regimens of this intensity. The authors say: "It is possible that either AET, RT or CT may be easier to perform effectively without supervision, thus affecting the external validity of these results since only studies with supervised training were included."

They add: "This systematic review and meta-analysis focused on randomized controlled trials comparing AET, RT and CT. Compared with AET or RT, CT interventions resulted in significantly more pronounced improvements in variables related to blood sugar control. With respect to single types of exercise intervention, AET was more effective in reducing HbA1c and fasting glucose when compared with RT. However, the interpretation of these findings with respect to their clinical relevance is limited by the overall low to moderate quality of the studies included, the lack of information on clinically important outcomes, and the limited information on the adverse effects of exercise."

They conclude: "Further high quality with long-term exercise interventions are needed to develop definitive recommendations. In the meantime, combined aerobic and resistance training can be recommended as part of a lifestyle programme in the management of type 2 diabetes wherever possible. Due to the limited information on potential adverse effects of exercise, supervised workouts should be favoured, though of course we accept it is not possible for most people to have supervised workouts in the course of day-to-day living."


Story Source:

The above story is based on materials provided by Diabetologia. Note: Materials may be edited for content and length.


Journal Reference:

  1. Lukas Schwingshackl, Benjamin Missbach, Sofia Dias, Jόrgen Kφnig, Georg Hoffmann. Impact of different training modalities on glycaemic control and blood lipids in patients with type 2 diabetes: a systematic review and network meta-analysis. Diabetologia, 2014; DOI: 10.1007/s00125-014-3303-z

Cite This Page:

Diabetologia. "Combined aerobic, resistance training, rather than either method alone, is best for controlling blood sugar in people with diabetes." ScienceDaily. ScienceDaily, 2 July 2014. <www.sciencedaily.com/releases/2014/07/140702203818.htm>.
Diabetologia. (2014, July 2). Combined aerobic, resistance training, rather than either method alone, is best for controlling blood sugar in people with diabetes. ScienceDaily. Retrieved July 22, 2014 from www.sciencedaily.com/releases/2014/07/140702203818.htm
Diabetologia. "Combined aerobic, resistance training, rather than either method alone, is best for controlling blood sugar in people with diabetes." ScienceDaily. www.sciencedaily.com/releases/2014/07/140702203818.htm (accessed July 22, 2014).

Share This




More Health & Medicine News

Tuesday, July 22, 2014

Featured Research

from universities, journals, and other organizations


Featured Videos

from AP, Reuters, AFP, and other news services

Gilead's $1000-a-Pill Drug Could Cure Hep C in HIV-Positive People

Gilead's $1000-a-Pill Drug Could Cure Hep C in HIV-Positive People

TheStreet (July 21, 2014) — New research shows Gilead Science's drug Sovaldi helps in curing hepatitis C in those who suffer from HIV. In a medical study, the combination of Gilead's Hep C drug with anti-viral drug Ribavirin cured 76% of HIV-positive patients suffering from the most common hepatitis C strain. Hepatitis C and related complications have been a top cause of death in HIV-positive patients. Typical medication used to treat the disease, including interferon proteins, tended to react badly with HIV drugs. However, Sovaldi's %1,000-a-pill price tag could limit the number of patients able to access the treatment. TheStreet's Keris Lahiff reports from New York. Video provided by TheStreet
Powered by NewsLook.com
$23.6 Billion Awarded To Widow In Smoking Lawsuit

$23.6 Billion Awarded To Widow In Smoking Lawsuit

Newsy (July 20, 2014) — Cynthia Robinson claims R.J. Reynolds Tobacco Company hid the health and addiction risks of its products, leading to the death of her husband in 1996. Video provided by Newsy
Powered by NewsLook.com
Tooth Plaque Provides Insight Into Diets Of Ancient People

Tooth Plaque Provides Insight Into Diets Of Ancient People

Newsy (July 19, 2014) — Research on plaque from ancient teeth shows that our prehistoric ancestor's had a detailed understanding of plants long before developing agriculture. Video provided by Newsy
Powered by NewsLook.com
Contaminated Water Kills 3 Babies in South African Town

Contaminated Water Kills 3 Babies in South African Town

AFP (July 18, 2014) — Contaminated water in South Africa's northwestern town of Bloemhof kills three babies and hospitalises over 500 people. The incident highlights growing fears over water safety in South Africa. Duration: 02:22 Video provided by AFP
Powered by NewsLook.com

Search ScienceDaily

Number of stories in archives: 140,361

Find with keyword(s):
 
Enter a keyword or phrase to search ScienceDaily for related topics and research stories.

Save/Print:
Share:  

Breaking News:
from the past week

In Other News

... from NewsDaily.com

Science News

Health News

Environment News

Technology News



Save/Print:
Share:  

Free Subscriptions


Get the latest science news with ScienceDaily's free email newsletters, updated daily and weekly. Or view hourly updated newsfeeds in your RSS reader:

Get Social & Mobile


Keep up to date with the latest news from ScienceDaily via social networks and mobile apps:

Have Feedback?


Tell us what you think of ScienceDaily -- we welcome both positive and negative comments. Have any problems using the site? Questions?
Mobile iPhone Android Web
Follow Facebook Twitter Google+
Subscribe RSS Feeds Email Newsletters
Latest Headlines Health & Medicine Mind & Brain Space & Time Matter & Energy Computers & Math Plants & Animals Earth & Climate Fossils & Ruins